TCT-64 Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial

Ashok Seth; Yoshinobu Onuma; Ricardo A. Costa; Praveen Chandra; Vinay K. Bahl; Cholenahally Nanjappa Manjunath; Ajaykumar Umakant Mahajan; Viveka Kumar; Parvin Kumar Goel; Gurpreet Singh Wander; Samuel R. Mathews; Upendra Kaul; Ajit Kumar Valaparambil; Pratap Chandra Rath; Vijay Trehan; Sengottuvelu Gunasekaran; Sundeep Mishra; Alexandre Abizaid; Patrick W. Serruys

doi:10.1016/j.jacc.2018.08.1153

Related publications

Article2020

TCT CONNECT-271 The MeRes-1 Extend Trial: 2-Year Clinical and 6-Month Imaging Outcomes of Thin-Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

Alexandre Abizaid, Saško Kedev, Rosli Bin Mohd Ali, Teguh Santoso, Ángel Cequier, Robert‐Jan van Geuns, Bernard Chevalier, Farrel Hellig, Ricardo A. Costa, Yoshinobu Onuma, J. Ribamar Costa, Patrick W. Serruys, Sripal Bangalore

Journal of the American College of Cardiology

Article2019

Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial

Ashok Seth, Yoshinobu Onuma, Praveen Chandra, Vinay K. Bahl, Cholenahally Nanjappa Manjunath, Ajaykumar Umakant Mahajan, Viveka Kumar, Praveen Goel, Gurpreet Singh Wander, Upendra Kaul, V K Ajit Kumar, Alexandre Abizaid, Patrick W. Serruys

EuroIntervention

Article2020

Imaging and 2‐year clinical outcomes of thin strut <scp>sirolimus‐eluting</scp> bioresorbable vascular scaffold: The <scp>MeRes</scp>‐1 extend trial

Alexandre Abizaid, Saško Kedev, Rosli Bin Mohd Ali, Teguh Santoso, Ángel Cequier, Robert‐Jan Van Geuns van Geuns, Bernard Chevalier, Farrel Hellig, Ricardo A. Costa, Yoshinobu Onuma, J. Ribamar Costa, Patrick W. Serruys, Sripal Bangalore

Catheterization and Cardiovascular Interventions

Article2017

First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial

Ashok Seth, Yoshinobu Onuma, Ricardo A. Costa, Praveen Chandra, Vinay K. Bahl, Cholenahally Nanjappa Manjunath, Ajaykumar Umakant Mahajan, Viveka Kumar, Pravin K. Goel, Gurpreet Singh Wander, Mathew Samuel Kalarickal, Upendra Kaul, V K Ajit Kumar, Pratap Chandra Rath, Vijay Trehan, Gunasekaran Sengottuvelu, Sundeep Mishra, Alexandre Abizaid, Patrick W. Serruys

EuroIntervention

Article2018

TCT-62 Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Patrick W. Serruys, Bernard Chevalier